323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2021W)
Prüfungsimmanente Lehrveranstaltung
Labels
GEMISCHT
Präsenz oder Hybrid oder Online, je nach Situation.
01.10.2021 13.15-16.00 Uhr HS 5
04.10.2021 13.15-16.30 Uhr HS 7
05.10.2021
06.10.2021
07.10.2021
08.10.2021
11.10.2021 14.00-17.00 Uhr 2D313
12.10.2021 14.00-17.00 Uhr 2D313
13.10.2021
14.10.2021 14.00-17.00 Uhr 2D313
15.10.2021 14.00-17.00 Uhr 2D313
18.10.2021 14.00-17.00 Uhr 2D313
19.10.2021 14.00-17.00 Uhr LAB
22.10.2021 13.15-16.30 Uhr HS 8
01.10.2021 13.15-16.00 Uhr HS 5
04.10.2021 13.15-16.30 Uhr HS 7
05.10.2021
06.10.2021
07.10.2021
08.10.2021
11.10.2021 14.00-17.00 Uhr 2D313
12.10.2021 14.00-17.00 Uhr 2D313
13.10.2021
14.10.2021 14.00-17.00 Uhr 2D313
15.10.2021 14.00-17.00 Uhr 2D313
18.10.2021 14.00-17.00 Uhr 2D313
19.10.2021 14.00-17.00 Uhr LAB
22.10.2021 13.15-16.30 Uhr HS 8
Details
Sprache: Englisch
Lehrende
Termine (iCal) - nächster Termin ist mit N markiert
Freitag
01.10.
13:15 - 17:00
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Montag
04.10.
13:15 - 16:30
UZA2 Hörsaal 7 (Raum 2Z210) 2.OG
Dienstag
05.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch
06.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Donnerstag
07.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Freitag
08.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
UZA2 Hörsaal 4 (Raum 2Z221) 2.OG
UZA2 Hörsaal 4 (Raum 2Z221) 2.OG
Montag
11.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Dienstag
12.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch
13.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Donnerstag
14.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Freitag
15.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Montag
18.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Freitag
22.10.
13:15 - 16:30
UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
Information
Ziele, Inhalte und Methode der Lehrveranstaltung
The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.
Art der Leistungskontrolle und erlaubte Hilfsmittel
There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the
material collected during the class and the studies for the class.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the
material collected during the class and the studies for the class.
Mindestanforderungen und Beurteilungsmaßstab
The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.
Prüfungsstoff
All topics covered during the course.
Literatur
Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)
Zuordnung im Vorlesungsverzeichnis
Letzte Änderung: Fr 01.04.2022 09:09